Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MPP And IGBA Initiatives Bolster COVID-19 Access

18 Companies Sign Up To MPP Pledge

Executive Summary

The Medicines Patent Pool and the International Generic and Biosimilar medicines Association have announced separate initiatives with the continued intention to facilitate access to COVID-19 treatments and vaccines, as the global threat from the novel coronavirus pandemic continues.

You may also be interested in...



WHO Launches COVID-19 Technology Access Pool

C-TAP, the voluntary initiative aimed at making vaccines, tests, treatments and other health technologies to fight COVID-19 accessible to all, has been launched by the WHO, in partnership with Costa Rica.

IGBA Backs Global Coronavirus Initiative

The IGBA has lent its backing to the Access to COVID-19 Tools (ACT) Accelerator initiative launched by the WHO that is aimed at speeding the development and production of – as well as access to – essential health technologies for addressing the coronavirus pandemic.

Patent Pool Expands Remit To COVID-19

The Medicines Patent Pool has expanded its mandate to include treatments that will aid the global response to the coronavirus pandemic.

Topics

Latest News
See All
UsernamePublicRestriction

Register

GB150430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel